Filing Details
- Accession Number:
- 0001209191-13-053042
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-19 15:08:40
- Reporting Period:
- 2013-11-15
- Filing Date:
- 2013-11-19
- Accepted Time:
- 2013-11-19 15:08:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1117480 | Chimerix Inc | CMRX | Pharmaceutical Preparations (2834) | 330903395 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1571865 | W. Timothy Trost | C/O Chimerix, Inc. 2505 Meridian Parkway, Suite 340 Durham NC 27713 | Svp, Cfo & Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-15 | 3,409 | $0.00 | 3,409 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-15 | 3,409 | $15.63 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common | Restricted Stock Unit | Disposition | 2013-11-15 | 3,409 | $0.00 | 3,409 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-11-15 | No | 4 | M | Direct |
Footnotes
- Acquisition resulted from the settlement of restricted stock units for common stock.
- The sales reported in the Form 4 were effected pursuant to a Rule 10B5-1 Plan adopted by the reporting person on September 5, 2013.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.21 to $16.05, inclusive. The reporting person undertakes to provide to CMRX, any security holder of CMRX, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
- Not applicable.
Billionaire Hedge Funds
